Literature DB >> 12449521

Spatial distribution of nociceptive neuropeptide and nerve growth factor depletion in experimental diabetic peripheral nervous system.

H Kanbayashi1, H Itoh, T Kashiwaya, K Atoh, I Makino.   

Abstract

This study investigated the time-course of the nociceptive neuropeptide substance P and nerve growth factor (NGF), which facilitates substance P production, in lumbar and cervical dorsal root ganglia (DRG) of streptozotocin-induced diabetic rats. Levels of substance P and NGF were measured by radioimmunoassay and sandwich enzyme-linked immunosorbent assay, respectively, 2 months, 4 months and 8 months after induction of diabetes, and compared with age-matched non-diabetic control rats. At 2 months and 4 months, substance P and NGF levels were lower in the lumbar DRG of the diabetic rats than in controls. At 8 months, substance P and NGF were lower in both the lumbar and cervical DRG of the diabetic rats than in controls. These data demonstrate that a decrease in substance P levels in primary sensory neurons with NGF depletion occurs in an axonal length-dependent manner in diabetic rats, and that this decrease may be correlated with the duration of diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12449521     DOI: 10.1177/147323000203000507

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  4 in total

1.  Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice.

Authors:  Kristina K Beiswenger; Nigel A Calcutt; Andrew P Mizisin
Journal:  Neurosci Lett       Date:  2008-07-03       Impact factor: 3.046

2.  Rab7 silencing prevents μ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy.

Authors:  Shaaban A Mousa; Mohammed Shaqura; Baled I Khalefa; Christian Zöllner; Laura Schaad; Jonas Schneider; Toni S Shippenberg; Jan F Richter; Rainer Hellweg; Mehdi Shakibaei; Michael Schäfer
Journal:  Diabetes       Date:  2012-12-10       Impact factor: 9.461

3.  Cerebrolysin improves sciatic nerve dysfunction in a mouse model of diabetic peripheral neuropathy.

Authors:  Han-Yu Dong; Xin-Mei Jiang; Chun-Bo Niu; Lin Du; Jun-Yan Feng; Fei-Yong Jia
Journal:  Neural Regen Res       Date:  2016-01       Impact factor: 5.135

4.  Sericin protects against diabetes-induced injuries in sciatic nerve and related nerve cells.

Authors:  Chengjun Song; Zhenjun Yang; Meirong Zhong; Zhihong Chen
Journal:  Neural Regen Res       Date:  2013-02-25       Impact factor: 5.135

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.